CD24 and neoplasm: In addition to CD29 and CD24, the percentage of GFP+ cells were also analyzed and a higher percentage of GFP+ cells was found in the second transplantation round of the p53−/− tumor compared to the first round tumor result (Supplementary Figure 1G), consistent with the increase in TICs reported in Figure 1C.